Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

61.45
+0.52160.86%
Post-market: 61.450.00000.00%19:30 EDT
Volume:192.56K
Turnover:11.76M
Market Cap:271.61M
PE:20.10
High:62.12
Open:61.37
Low:60.40
Close:60.93
52wk High:64.10
52wk Low:39.36
Shares:4.42M
Float Shares:4.42M
Volume Ratio:6.46
T/O Rate:4.36%
Dividend:1.53
Dividend Rate:2.48%
EPS(TTM):3.06
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

BrightSpring Health Q2 Adj. EPS $0.45 Beats $0.40 Estimate, Sales $3.873B Beat $3.658B Estimate

Benzinga Earnings
·
Jul 31

Brightspring Health Services Q2 Net Income USD 87 Million

THOMSON REUTERS
·
Jul 31

Brightspring Health Services - Sees Fy2026 Revenue $15.10 Bln-$15.43 Bln, up 17%-19.5%

THOMSON REUTERS
·
Jul 31

Brightspring Health Services Inc Fy2026 REV View $15.06 Bln

THOMSON REUTERS
·
Jul 31

Brightspring Health Services - Sees Fy2026 Adj Ebitda $820 Mln-$845 Mln, up 32.8%-36.8%

THOMSON REUTERS
·
Jul 31

Brightspring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance

THOMSON REUTERS
·
Jul 31

BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance

GlobeNewswire
·
Jul 31

Guardant Health Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Guardant Health Inc : RBC Raises Target Price to $200 from $185

THOMSON REUTERS
·
Jul 31

Guardant Health files automatic mixed securities shelf

TIPRANKS
·
Jul 31

Guardant Health Inc Files for Mixed Shelf Offering; Size not Disclosed- SEC Filing

THOMSON REUTERS
·
Jul 31

Guardant Health Q2 Adjusted Loss Narrows, Revenue Rises

MT Newswires Live
·
Jul 31

Guardant Health Q2 Adj. EPS $(0.42) Misses $(0.41) Estimate, Sales $334.978M Beat $314.226M Estimate

Benzinga Earnings
·
Jul 31

Guardant Health Q2 Adjusted EPS USD -0.42 Vs. IBES Estimate USD -0.41

Reuters
·
Jul 31

Guardant Health - Sees 2026 Free Cash Flow Burn $195-$205 Mln

THOMSON REUTERS
·
Jul 31

Roivant President, Immunovant CEO Eric Venker Sells USD 6.99 Million in Common Shares

Reuters
·
Jul 30

Revolution Medicines to Report Q2 Financial Results After Market Close, Hosts Webcast Update

Reuters
·
Jul 30

Guardant Health to Present at Canaccord Genuity Growth Conference Fireside Chat

Reuters
·
Jul 30

Roivant Sciences Announces Annual General Meeting of Shareholders

Reuters
·
Jul 29

Imeik Technology Obtains Medical Device Registration Certificate for Cross-Linked Gel Product

Stock News
·
Jul 29